483 Hybio Pharmaceutical Mar 2018

483 Hybio Pharmaceutical Mar 2018

$119 - Not in Stock

FDA investigators audited the Hybio Pharmaceutical - Shenzhen, China facility and issued inspectional observations (via FDA 483) on 30 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Mar 2018
  • Location: Shenzhen, China
  • FEI: 3010165930

Pre-Order Not Available